Paper146331
[Combination chemotherapy in patients with disseminated bronchogenic carcinoma (author's transl)].
Gropp C and 6 others. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol, 1977. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. [Combination chemotherapy in patients with disseminated bronchogenic carcinoma (author's transl)]. Papers, record 146331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/146331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Carcinoma, Bronchogenic | Major topic |
| Lung Neoplasms | Major topic |
| Neoplasm Metastasis | Major topic |
| Cyclophosphamide | |
| Doxorubicin | |
| Drug Therapy, Combination | |
| Humans | |
| Vincristine |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 56980 | BACON (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients. | Cancer | 1976 | https://conductscience.org/library/papers/56980 | PubMed |
| 2 | 71943 | Therapy of advanced squamous carcinoma of the lung: cyclophosphamide vesus "COMB". | Cancer | 1977 | https://conductscience.org/library/papers/71943 | PubMed |
| 3 | 187313 | Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine. | Cancer | 1976 | https://conductscience.org/library/papers/187313 | PubMed |
| 4 | 4729328 | Aspects of the immunologic treatment of lung cancer. | Cancer Chemother Rep 3 | 1973 | https://conductscience.org/library/papers/4729328 | PubMed |
| 5 | 171056 | Combination chemotherapy in oat cell carcinoma of the lung. | Cancer | 1975 | https://conductscience.org/library/papers/171056 | PubMed |
| 6 | 5791000 | Alkylating agents in bronchogenic carcinoma. | Am J Med | 1969 | https://conductscience.org/library/papers/5791000 | PubMed |
| 7 | 4718672 | A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne metastases. | Cancer Res | 1973 | https://conductscience.org/library/papers/4718672 | PubMed |
| 8 | 5905473 | Effect of prolonged coumadin treatment on the production of pulmonary metastases in the rat. | Cancer | 1966 | https://conductscience.org/library/papers/5905473 | PubMed |
| 9 | 187312 | Combination chemotherapy of advanced lung cancer: a randomized trial. | Cancer | 1976 | https://conductscience.org/library/papers/187312 | PubMed |
| 10 | 4559404 | Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma. | Cancer | 1972 | https://conductscience.org/library/papers/4559404 | PubMed |
| 11 | 832600 | [Integrated chemotherapy and radiotherapy of inoperable bronchial carcinoma: preliminary results in 50 cases (author's transl)]. | Dtsch Med Wochenschr | 1977 | https://conductscience.org/library/papers/832600 | PubMed |
| 12 | 1203841 | Heparin and chemotherapy in the management of inoperable lung carcinoma. | Cancer | 1975 | https://conductscience.org/library/papers/1203841 | PubMed |
| 13 | 181121 | Oat cell carcinoma of the lung. Early treatment results of combination radiation therapy and chemotherapy. | Cancer | 1976 | https://conductscience.org/library/papers/181121 | PubMed |
| 14 | 55647 | A 5-year controlled study of B.C.G. and radiotherapy inoperable lung cancer. | Lancet | 1976 | https://conductscience.org/library/papers/55647 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 7309780 | Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systems. | J Cancer Res Clin Oncol | 1981 | https://conductscience.org/library/papers/7309780 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/146331
GET https://conductscience.org/api/papers/v1/146331/authors